• About us
• Contact

Advertisement

Organisation › Details

Almac Diagnostics Ltd.

Almac Diagnostics, a division of the Almac Group develops and delivers novel genomic research products, such as the Breast Cancer DSA™ research tool, to help accelerate the drug discovery pipeline from validation to market. Using the range of proprietary Cancer DSA™ research tools, Almac Diagnostics develops clinical tests to improve the diagnosis and treatment of cancer patients. The company also operates an accredited genomic services division, enabling academia, biotech and pharmaceutical companies to access high quality microarray processing and bioinformatics capabilities on an outsource basis. Almac Diagnostics aims to be a global leader in the provision of genomic based solutions for the advancement of patient care *

 

	Start	2006-01-10 renamed
	Group	Almac (Group)
	Predecessor	ArraDx Ltd.
	Industry	GeneChip® services
	Industry 2	diagnostics (medical/biological)
	Region	Craigavon
	Country	United Kingdom (GB)
	Street	Seagoe Industrial Estate
	City	BT63 5QD Craigavon
	Tel	+44-28-3833-7575
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2017-04-01

Advertisement

More documents for Almac (Group)

• [1] Vaderis Therapeutics AG. (8/22/22). "Press Release: Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT". Basel....
• [2] Almac Group Ltd.. (2/28/18). "Press Release: Almac Group Expands with Opening of £20 Million Cold Chain Facility". Craigavon....
• [3] Almac Group Ltd.. (1/23/18). "Press Release: Almac Group Implements Salesforce Service Cloud to Enhance Client and Clinical Site User Experience". Souderton, PA....
• [4] Almac Group Ltd.. (1/18/18). "Press Release: Almac Group Announces Further Expansion at Its European Campus in Dundalk". Craigavon....
• [5] Almac Group Ltd.. (11/1/17). "Press Release: Almac Group Announces Acquisition of BioClin Laboratories". Craigavon....
• [6] Debiopharm International SA. (6/20/17). "Press Release: Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor". Craigavon & Lausanne....
• [7] Almac Group Ltd.. (2/16/17). "Press Release: Almac Diagnostics Appoints Dr Leeona Galligan as Vice President UK Operations". Craigavon....
• [8] Almac Group Ltd.. (2/14/17). "Press Release: RCSI and Almac Discovery Enter Research Collaboration to Target Therapy-resistant Cancer Tumours". Craigavon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.